Condition: Metastatic Prostate Cancer (mPC) · Sponsor: European Institute of Oncology
Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration
This description comes directly from the study's public registry record.
Elena Guerini Rocco, MD · 00390294372871 · elena.guerinirocco@ieo.it
francesca lombardi, biologist · 00390257489425 · francesca.lombardi@ieo.it
Always discuss trial participation with your own doctor first.
| European Institute of oncology | Milan, Italy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06762379